Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Mimedx Group (MDXG) Accumulated Depreciation & Amortization: 2011-2025

Historic Accumulated Depreciation & Amortization for Mimedx Group (MDXG) over the last 13 years, with Sep 2025 value amounting to $23.0 million.

  • Mimedx Group's Accumulated Depreciation & Amortization rose 8.01% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year increase of 7.33%. This contributed to the annual value of $21.3 million for FY2024, which is 6.46% up from last year.
  • As of Q3 2025, Mimedx Group's Accumulated Depreciation & Amortization stood at $23.0 million, which was up 2.40% from $22.4 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's Accumulated Depreciation & Amortization peaked at $37.9 million during Q3 2023, and registered a low of $20.0 million during Q4 2023.
  • For the 3-year period, Mimedx Group's Accumulated Depreciation & Amortization averaged around $25.7 million, with its median value being $21.9 million (2025).
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first grew by 17.90% in 2021, then slumped by 44.25% in 2023.
  • Over the past 5 years, Mimedx Group's Accumulated Depreciation & Amortization (Quarterly) stood at $32.9 million in 2021, then rose by 9.27% to $35.9 million in 2022, then crashed by 44.25% to $20.0 million in 2023, then climbed by 6.46% to $21.3 million in 2024, then rose by 8.01% to $23.0 million in 2025.
  • Its last three reported values are $23.0 million in Q3 2025, $22.4 million for Q2 2025, and $21.9 million during Q1 2025.